🔎 Trials Near Me

Hjem › Sigdcelleanemi › Georgia › Atlanta

Kliniske studier for Sigdcelleanemi i Atlanta, GA

22 studier for Sigdcelleanemi søker deltakere på steder i og rundt Atlanta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

RekruttererFase 1
  • Emory University, Atlanta
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07187973

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

RekruttererFase 3
  • WCG Sonar Clinical Research, Riverdale · 12 mi unna
Alder 12 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

RekruttererFase 3
  • Children's Healthcare Atlanta, Atlanta
Alder 2 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

RekruttererFase 3
  • Children's Healthcare Atlanta, Atlanta
Alder 12 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06612268

Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing

Rekrutterer
  • Children's Healthcare of Atlanta, Atlanta
Alder 8 til 18 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07562451

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

RekruttererFase 2/3
  • Children's Center for Advanced Pediatrics, Atlanta
Alder 12 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
  • Winship Cancer Institute of Emory University, Atlanta
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

RekruttererObservasjonsstudie
  • Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
  • Emory/Children's Health Care of Atlanta, Atlanta
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

RekruttererFase 2
  • Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
Alder 12 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

RekruttererFase 2
  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT07224360

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

RekruttererFase 1/2
  • Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Alder 7 til 21 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT02447874

Cooperative Assessment of Late Effects for SCD Curative Therapies

RekruttererObservasjonsstudie
  • Emory University School of Medicine, Atlanta
Alder 4 til 65 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

RekruttererObservasjonsstudie
  • Children's Healthcare of Atlanta (MRD-HCT), Atlanta
Alder 3 til 20 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06941389

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

RekruttererFase 1/2
  • Children's Healthcare of Atlanta, Atlanta
Alder 12 til 45 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT07252050

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

RekruttererFase 4
  • Emory University, Atlanta
Alder 18 til 50 · Kvinner · Oppdatert 28. mai 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

Rekrutterer
  • Children's Healthcare of Atlanta, Atlanta
Alder 13 til 21 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06290401

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

RekruttererFase 3
  • Site # 8400006, Atlanta
  • Site # 8400002, Atlanta
Alder 2 til 17 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT07247188

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

RekruttererFase 4Frivillige helsepersonell ønskes velkommen
  • Grady Health System, Atlanta
Alder 18 og eldre · Kvinner · Oppdatert 18. feb. 2026 · NCT06979492

A Long-term Follow-up Study in Patients Who Received BEAM-101

RekruttererObservasjonsstudie
  • Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
Alder 14 til 37 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT07373639

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

Rekrutterer
  • Children's Hospital of Atlanta: Eagelston, Atlanta
Alder 7 til 18 · Alle kjønn · Oppdatert 26. jan. 2026 · NCT07090668

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Rekrutterer
  • Children's Healthcare of Atlanta, Atlanta
Alder 16 til 30 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT06374238

Integrative Training Program for Pediatric Sickle Cell Pain

Rekrutterer
  • Children's Healthcare of Atlanta, Atlanta
  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Alder 12 til 18 · Alle kjønn · Oppdatert 14. nov. 2025 · NCT06691867

Sigdcelleanemi-studier i andre byer

Andre studier i Atlanta

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.